CP1 0.00% 17.0¢ cannpal animal therapeutics limited

Ann: CannPal Enters into Exclusive Licencing Agreement with CSIRO, page-6

  1. 7,388 Posts.
    lightbulb Created with Sketch. 829
    Is it accurate that estimated annual revenue could be in the tens of millions if their CPAT-01 product makes it to market?!

    stats.png
    And they also have this "nutraceutical" in the pipeline too - wtf?!

    nutra.png
    Why is nobody talking about this @ 10 million AUD market cap?!
 
watchlist Created with Sketch. Add CP1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.